These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30195754)

  • 1. Circulating miRNAs as Predictive Biomarkers of Type 2 Diabetes Mellitus Development in Coronary Heart Disease Patients from the CORDIOPREV Study.
    Jiménez-Lucena R; Rangel-Zúñiga OA; Alcalá-Díaz JF; López-Moreno J; Roncero-Ramos I; Molina-Abril H; Yubero-Serrano EM; Caballero-Villarraso J; Delgado-Lista J; Castaño JP; Ordovás JM; Pérez-Martinez P; Camargo A; López-Miranda J
    Mol Ther Nucleic Acids; 2018 Sep; 12():146-157. PubMed ID: 30195754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNAs profile as biomarkers of nutritional therapy for the prevention of type 2 diabetes mellitus: From the CORDIOPREV study.
    Jimenez-Lucena R; Alcala-Diaz JF; Roncero-Ramos I; Lopez-Moreno J; Camargo A; Gomez-Delgado F; Quintana-Navarro GM; Vals-Delgado C; Rodriguez-Cantalejo F; Luque RM; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Rangel-Zuñiga OA; Lopez-Miranda J
    Clin Nutr; 2021 Mar; 40(3):1028-1038. PubMed ID: 32723508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study.
    Jiménez-Lucena R; Camargo A; Alcalá-Diaz JF; Romero-Baldonado C; Luque RM; van Ommen B; Delgado-Lista J; Ordovás JM; Pérez-Martínez P; Rangel-Zúñiga OA; López-Miranda J
    Exp Mol Med; 2018 Dec; 50(12):1-12. PubMed ID: 30598522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study.
    Rangel-Zuñiga OA; Vals-Delgado C; Alcala-Diaz JF; Quintana-Navarro GM; Krylova Y; Leon-Acuña A; Luque RM; Gomez-Delgado F; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
    Mol Ther Nucleic Acids; 2021 Mar; 23():255-263. PubMed ID: 33425484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients.
    Mahjoob G; Ahmadi Y; Fatima Rajani H; Khanbabaei N; Abolhasani S
    J Clin Lab Anal; 2022 May; 36(5):e24380. PubMed ID: 35349731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating early- and mid-pregnancy microRNAs and risk of gestational diabetes.
    Wander PL; Boyko EJ; Hevner K; Parikh VJ; Tadesse MG; Sorensen TK; Williams MA; Enquobahrie DA
    Diabetes Res Clin Pract; 2017 Oct; 132():1-9. PubMed ID: 28783527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.
    Liang Z; Gao KP; Wang YX; Liu ZC; Tian L; Yang XZ; Ding JY; Wu WT; Yang WH; Li YL; Zhang ZB; Zhai RH
    Am J Physiol Endocrinol Metab; 2018 Sep; 315(3):E374-E385. PubMed ID: 29812988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus.
    Samandari N; Mirza AH; Nielsen LB; Kaur S; Hougaard P; Fredheim S; Mortensen HB; Pociot F
    Diabetologia; 2017 Feb; 60(2):354-363. PubMed ID: 27866223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis.
    Tavano F; Fontana A; Mazza T; Gioffreda D; Biagini T; Palumbo O; Carella M; Andriulli A
    Front Oncol; 2020; 10():1567. PubMed ID: 33072549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population　- Six-Year Follow-up Results From the China-Cardiovascular Disease Study.
    Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H
    Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
    Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
    Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma circulating miR-23~27~24 clusters correlate with the immunometabolic derangement and predict C-peptide loss in children with type 1 diabetes.
    Garavelli S; Bruzzaniti S; Tagliabue E; Di Silvestre D; Prattichizzo F; Mozzillo E; Fattorusso V; La Sala L; Ceriello A; Puca AA; Mauri P; Strollo R; Marigliano M; Maffeis C; Petrelli A; Bosi E; Franzese A; Galgani M; Matarese G; de Candia P
    Diabetologia; 2020 Dec; 63(12):2699-2712. PubMed ID: 32728892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus.
    Weale CJ; Matshazi DM; Davids SFG; Raghubeer S; Erasmus RT; Kengne AP; Davison GM; Matsha TE
    Diabetes Metab Syndr Obes; 2020; 13():5037-5047. PubMed ID: 33376373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
    Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
    J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients.
    Ye D; Zhang T; Lou G; Xu W; Dong F; Chen G; Liu Y
    Life Sci; 2018 Sep; 208():201-207. PubMed ID: 30030064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.